Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Peritoneal washing cytology.

P Shield1

  • 1Department of Cytology, Sullivan Nicolaides Pathology, Brisbane, Qld, Australia. paul_shield@snp.com.au

Cytopathology : Official Journal of the British Society for Clinical Cytology
|May 29, 2004
PubMed
Summary

Peritoneal washing cytology (PWC) aids in diagnosing ovarian tumors and staging. Distinguishing malignant cells from benign mimics in PWC is crucial for accurate patient management and prognosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Approach to thyroid cytology: rationale for standardisation.

Pathology·2015
Same author

Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC.

Physical review letters·2011
Same author

Establishment of a cell line from a hepatocellular carcinoma from a patient with hemochromatosis.

Hepatology (Baltimore, Md.)·1994
Same author

Monoclonal antibodies reacting with the MUC2 mucin core protein.

British journal of cancer·1993
Same author

Stimulus overinclusion in schizophrenic disorders.

Archives of general psychiatry·1972

Area of Science:

  • Cytopathology
  • Gynecologic Oncology
  • Surgical Pathology

Background:

  • Peritoneal washing cytology (PWC) is valuable for detecting ovarian tumor spread and staging, especially for non-serous types.
  • The prognostic significance of PWC for endometrial carcinoma remains uncertain due to questions about peritoneal involvement.
  • Identifying metastatic carcinoma in PWC relies on recognizing non-mesothelial cell features.

Purpose of the Study:

  • To clarify the utility of PWC in gynecologic oncology, focusing on ovarian and endometrial malignancies.
  • To highlight the challenges in interpreting PWC, including distinguishing malignant cells from benign mimics.
  • To provide guidance on accurate PWC interpretation for improved patient staging and prognosis.

Main Methods:

  • Review of PWC findings in cases of ovarian and endometrial tumors.
  • Analysis of cytomorphological features differentiating malignant cells from reactive mesothelial cells, endometriosis, and endosalpingiosis.
  • Correlation of PWC results with clinical history and surgical pathology findings.

Main Results:

  • PWC effectively identifies ovarian surface involvement and peritoneal dissemination, aiding staging and prognosis.
  • Benign conditions like reactive mesothelial cells, endometriosis, and endosalpingiosis can mimic malignant cells in PWC.
  • Specific cytological features (e.g., cilia, lack of single atypical cells, vacuolation) suggest a benign process.

Conclusions:

  • PWC is a valuable tool for staging ovarian cancer and detecting subclinical peritoneal spread.
  • Careful attention to cytomorphological details and correlation with clinical/pathological data are essential to avoid misinterpretation of PWC.
  • Cell blocks and special stains can assist in accurate PWC diagnosis.

Related Experiment Videos